CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 46 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $408,000 | -9.9% | 165,330 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $453,000 | +77.6% | 165,330 | 0.0% | 0.02% | +60.0% |
| Q3 2020 | $255,000 | -18.0% | 165,330 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $311,000 | +10.7% | 165,330 | 0.0% | 0.01% | -7.7% |
| Q1 2020 | $281,000 | -41.3% | 165,330 | 0.0% | 0.01% | -27.8% |
| Q4 2019 | $479,000 | +360.6% | 165,330 | 0.0% | 0.02% | +260.0% |
| Q3 2019 | $104,000 | -35.4% | 165,330 | 0.0% | 0.01% | -28.6% |
| Q2 2019 | $161,000 | -29.4% | 165,330 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $228,000 | +28.8% | 165,330 | 0.0% | 0.01% | +12.5% |
| Q4 2018 | $177,000 | -65.2% | 165,330 | +100.0% | 0.01% | -55.6% |
| Q3 2018 | $508,000 | -42.5% | 82,665 | 0.0% | 0.02% | -47.1% |
| Q2 2018 | $884,000 | – | 82,665 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
| BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
| Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
| WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
| Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
| XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
| Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
| Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
| SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |